| 1. | | | Activity of meropenem-vaborbactam against different beta-lactamase producing Klebsiella pneumoniae and Escherichia coli isolates in Iran
|
| 2. | | | Aminoglycoside resistance determinants in multiresistant Escherichia coli and Klebsiella pneumoniae clinical isolates from Turkish and Syrian patients
|
| 3. | | | Antibiotic resistance, virulence and genetic diversity of Klebsiella pneumoniae in community- and hospital-acquired urinary tract infections in Iran
|
| 4. | | | Antimicrobial resistance trends among Klebsiella pneumoniae associated with urinary tract infections in Crete, Greece, 2017-2022
|
| 5. | | | Association of fluoroquinolone resistance and ESBL production in hypervirulent Klebsiella pneumoniae ST11 and ST893 in Iran
|
| 6. | | | Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India
|
| 7. | | | Carbapenem-resistant Klebsiella pneumoniae in the Balkans: Clonal distribution and associated resistance determinants
|
| 8. | | | Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals
|
| 9. | | | Ceftazidime/avibactam resistance is associated with different mechanisms in KPC-producing Klebsiella pneumoniae strains
|
| 10. | | | Changes in molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in the intensive care units of a Greek hospital, 2018-2021
|
| 11. | | | Characteristics in the whole-genome sequence of Klebsiella pneumoniae ST147 from Turkey
|
| 12. | | | Colistin resistance associated with outer membrane protein change in Klebsiella pneumoniae and Enterobacter asburiae
|
| 13. | | | Detection of acrA, acrB, aac(6')-Ib-cr, and qepA genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae
|
| 14. | | | Detection of colistin resistance among multidrug-resistant Klebsiella pneumoniae and Escherichia coli clinical isolates in Turkey
|
| 15. | | | Detection of different colistin resistance mechanisms among multidrug resistant Klebsiella pneumoniae isolates in Bulgaria
|
| 16. | | | Detection of ESBL and AmpC producing Klebsiella pneumoniae ST11 and ST147 from urinary tract infections in Iran
|
| 17. | | | Detection of extensively drug-resistant and hypervirulent Klebsiella pneumoniae ST15, ST147, ST377 and ST442 in Iran
|
| 18. | | | Detection of NDM-1 producing Klebsiella pneumoniae ST15 and ST147 in Iran during 2019-2020
|
| 19. | | | Discrepancy between colistin and polymyxin B susceptibility results among Escherichia coli and Klebsiella pneumoniae clinical isolates
|
| 20. | | | Dissemination of ST274 Klebsiella pneumoniae epidemic clone in newborn and adult hospital settings harbouring SHV-2A or CTX-M-15 type extended spectrum ß-lactamases-producing known plasmids
|
| 21. | | | Effect of antimicrobial peptides on colistin-susceptible and colistin-resistant strains of Klebsiella pneumoniae and Enterobacter asburiae
|
| 22. | | | Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli
|
| 23. | | | The emergence of blaOXA-48 and blaNDM among ESBL-producing Klebsiella pneumoniae in clinical isolates of a tertiary hospital in Iran
|
| 24. | | | Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey
|
| 25. | | | Emergence of colistin-resistant Klebsiella pneumoniae in Poland
|
| 26. | | | Emergence of NDM-1 among carbapenem-resistant Klebsiella pneumoniae in Iraqi hospitals
|
| 27. | | | ESBL - (extended spectrum beta-laktamáz) termelő Klebsiella-izolátumok jelentősége
|
| 28. | | | ESBL-termelő Klebsiella pneumoniae Nemzeti PFGE adatbázisa
|
| 29. | | | First report of coexistence of AmpC beta-lactamase genes in Klebsiella pneumoniae strains isolated from burn patients
|
| 30. | | | Genetic support of carbapenemases in double carbapenemase producer Klebsiella pneumoniae isolated in the Arabian Peninsula
|
| 31. | | | Has the use of fluoroquinolones facilitated the widespread dissemination of methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase-producing Klebsiella pneumoniae in the heal...
|
| 32. | | | High rate of carbapenem-resistant Klebsiella pneumoniae detected from hospital equipments in Iran
|
| 33. | | | High-risk clonal lineages among extended-spectrum ß-lactamase producing Escherichia coli and Klebsiella pneumoniae from urban and rural stagnant water samples in Tunisia
|
| 34. | | | Hypervirulent Klebsiella pneumoniae: An update on epidemiology, detection and antibiotic resistance
|
| 35. | | | Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital
|
| 36. | | | Imipenem/cilasztatin/relebaktám: az új ß-laktám-ß-laktamáz-gátló kombináció
|
| 37. | | | In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia
|
| 38. | | | Investigation of carbapenem-resistant Enterobacterales isolates at a tertiary laboratory in Pretoria, South Africa
|
| 39. | | | Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains
|
| 40. | | | Investigation of NDM-1 and OXA-48 producing carbapenem resistant Klebsiella pneumoniae ST15 in Iran
|
| 41. | | | Investigations of carbapenem resistant and hypervirulent Klebsiella pneumoniae
|
| 42. | | | Kiterjedt-spektrumú ß-lactamase termelő Klebsiella pneumoniae a Neonatalis Intenzív Centrumban
|
| 43. | | | Klebsiella pneumoniae increases invasion in intestinal epithelial cells by disrupting the cytoskeleton
|
| 44. | | | Klebsiella pneumoniae okozta femur osteomyelitis esete
|
| 45. | | | KPC-2 and VIM-1 producing Klebsiella pneumoniae ST39 high-risk clone isolated from a clinical sample in Volos, Greece
|
| 46. | | | Low prevalence of hypervirulent Klebsiella pneumoniae in Anatolia, screened via phenotypic and genotypic testing
|
| 47. | | | Multiple detection of hypermucoviscous and hypervirulent strains of Klebsiella pneumoniae: An emergent health care threat
|
| 48. | | | A multirezisztens szuper baktériumok és a fluorokinolon hatás
|
| 49. | | | Mutation in mgrB is the major colistin resistance mechanism in Klebsiella pneumoniae clinical isolates in Tehran, Iran
|
| 50. | | | Next-generation sequencing of plasmid carrying blaOXA-48 in Klebsiella pneumoniae from Turkey
|
